| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e475d31449f99e552ef96d52ac16126 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J43-00 |
| filingDate |
2019-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a409a758afc1a860f34b1f14a6982f9 |
| publicationDate |
2020-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020135454-A1 |
| titleOfInvention |
Class of steroid compounds and use thereof |
| abstract |
Provided in the present invention are compounds of formulae (I), (II), (III) and (IV), a stereoisomer, a tautomer or a pharmaceutically acceptable salt thereof. Disclosed are a method for preparing such compounds and the use of the compounds in the treatment of diseases, such as various nervous system diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021188778-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11718642-B2 |
| priorityDate |
2018-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |